Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies

NCT06145841 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-11-24

No results posted yet for this study

Summary

This study aims to observe the effectiveness of clinical application in guiding anti-infection treatments in AIDS patients with severe pneumonia and/or sepsis using Metagenomic Next-Generation Sequencing-based technology in the real world

Conditions

Interventions

DIAGNOSTIC_TEST

Pathogen metagenomic next-generation sequencing

In diagnosing patients with AIDS combined with severe pneumonia and/or sepsis, use pathogen metagenomics technology to detect peripheral blood specimens

Sponsors & Collaborators

  • Guangzhou 8th People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-23
Primary Completion
2026-10-23
Completion
2027-10-23

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06145841 on ClinicalTrials.gov